Marc will be presenting the session, “Understanding the Impact of MFN and Tariffs on the Cell and Gene Therapy Sector,” on Wednesday, October 8 at 11 am MST highlighting global pricing policies such as MFN rules and evolving tariff structures, expanding on how they are reshaping the economics of cell and gene therapy and the real-world implications for developers, manufacturers, and investors.
Get in touch to meet with our ADVI experts and learn more about our insights and expertise.


